INDV
Indivior Pharmaceuticals, Inc.
A specialty pharmaceutical company focused on treating opioid addiction, Indivior makes Suboxone (a film that dissolves under the tongue) and Sublocade (a once-monthly injection) to help people recover, plus Opvee, a nasal spray that reverses opioid overdoses. It began in 1994 as a buprenorphine unit inside consumer-goods giant Reckitt Benckiser, then spun off in 2014 to become its own company. Its name is widely read as a nod to "individual" recovery—caring for the person, not just the condition.
CUSIP: 45579U109HealthcareUS2 holders
Jan 26, 2026 — Reclassified from Indivior Pharmaceuticals, Inc. (1:1)
Total Value
$214.01M
Total Shares
7.02M
Net Share Change
+7.02M
Activity
2 buying
Investor
Value
Shares
Weight
Change
